Search

Displaying results 7021 - 7030 of 10000 in total
  1. Drug

    Londamocitinib

    go.drugbank.com/drugs/DB19190
    Investigational

    Londamocitinib is under investigation in clinical trial NCT06020014 (Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-severe Asthma Uncontrolled on Medium-high

    Synonyms: (R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide, 1-piperazineacetamide, n-(3-(5-fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)-4-pyrimidinyl)-1h-indol-7-yl)-.alpha.-(methoxymethyl)-4-methyl-, (.alpha.r)-
  2. Drug

    Quinupramine

    go.drugbank.com/drugs/DB13246
    Approved

    Quinupramine has been approved in France under the brand name Kinupril, as an antidepressant [A175003].

  3. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    Ledaborbactam etzadroxil is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor. … Ledaborbactam etzadroxil is under investigation in clinical trial NCT06733675 (Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination).

  4. Drug

    CoVac-1

    go.drugbank.com/drugs/DB16429
    Investigational

    Sponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588]. … It is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC))[L30428] and aims to induce broad

  5. Drug

    Livmoniplimab

    go.drugbank.com/drugs/DB18939
    Investigational

    Livmoniplimab is under investigation in clinical trial NCT06109272 (A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination … With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)).

  6. Drug

    Ivarimod

    go.drugbank.com/drugs/DB19605
    Experimental

    Ivarimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Ivarimod is a immunomodulator, both stimulant/suppressive and stimulant. … Ivarimod has a monoisotopic molecular weight of 512.33 Da.

  7. Drug

    Epertinib

    go.drugbank.com/drugs/DB20062
    Experimental

    Epertinib is a small molecule drug. The usage of the INN stem '-ertinib' in the name indicates that Epertinib is a epidermal growth factor receptor (EGFR) inhibitor. … Epertinib has a monoisotopic molecular weight of 559.18 Da.

  8. Drug

    Quiflapon

    go.drugbank.com/drugs/DB20376
    Experimental

    Quiflapon is a small molecule drug. The usage of the INN stem '-flapon' in the name indicates that Quiflapon is a 5-lipoxygenase-activating protein (FLAP) inhibitor. … Quiflapon has a monoisotopic molecular weight of 586.21 Da.

  9. Drug

    Burapitant

    go.drugbank.com/drugs/DB20607
    Experimental

    Burapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1​ (substance P) receptor antagonist. … Burapitant has a monoisotopic molecular weight of 681.2 Da.

  10. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Adarigiline is a monoamine oxydase (MAO)-inhibitor type B. … Adarigiline has a monoisotopic molecular weight of 360.08 Da.